Tomas Hanke

Professor Tomas Hanke is a world famous scientist whose scientific research work is focused on immunology and infectious diseases. Currently he is working as a professor of Vaccine Immunology at the University of Oxford.

His research aims to develop a universal HIV-1 vaccine, which targets most global virus variants including escape mutants. He strives to maintain a balance between basic and translational research. He oversees a busy pre-clinical programme encompassing HIV-1 epitope discovery and dynamics using mass spectrometry and T-cell assays, studies on immunodominance, depth (number of variants) of epitope recognition and the importance of perfect vaccine-virus epitope matching for effective effector functions.

Prof. Hanke explores novel vaccine modalities and optimizes their immunogenicity in heterelogous prime-boost regimens in mice and macaques. He co-ordinates a clinical programme assessing candidate HIV vaccines in humans in UK, Europe and Africa.

assignment_turned_in Registrations
No Registration form is selected.
Please login to view this page.
Please login to view this page.
Please login to view this page.
No item in the cart
Go shopping!